Prescription Rates Decline for Novo and Lilly's Oral GLP-1 Drugs | Retatrutide News

Prescriptions for oral GLP-1 drugs from Novo Nordisk and Eli Lilly are declining. This trend may affect the market strategy for Retatrutide and other GL...
Market News · October 13, 2026